$5.42
-0.04[-0.73%]
At close: Apr 24
$5.42
0[0.00%]
After Hours: 7:17PM EDT
Editas Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Editas Medicine using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | EDIT | Q1 | -$0.71 | -$0.67 | — | — | $9.85M | $7.90M | — | — | Get Alert |
02/28/2024 | AM | EDIT | Q4 | -$0.88 | -$0.54 | -$0.23 | 57.41% | $6.54M | $7.94M | $60.05M | 656.30% | Get Alert |
11/03/2023 | AM | EDIT | Q3 | -$0.81 | -$0.57 | -$0.55 | 3.51% | $42.00K | $3.42M | $5.34M | 56.02% | Get Alert |
08/02/2023 | AM | EDIT | Q2 | -$0.78 | -$0.76 | -$0.56 | 26.32% | $6.36M | $6.28M | $2.89M | -54.03% | Get Alert |
05/05/2023 | AM | EDIT | Q1 | -$0.74 | -$0.78 | -$0.71 | 8.97% | $6.77M | $3.01M | $9.85M | 227.28% | Get Alert |
02/22/2023 | AM | EDIT | Q4 | -$0.61 | -$0.80 | -$0.88 | -10.00% | $12.47M | $3.26M | $6.54M | 100.49% | Get Alert |
11/02/2022 | AM | EDIT | Q3 | -$0.57 | -$0.86 | -$0.81 | 5.81% | $6.20M | $4.73M | $42.00K | -99.11% | Get Alert |
08/03/2022 | AM | EDIT | Q2 | -$0.81 | -$0.82 | -$0.78 | 4.88% | $379.00K | $4.29M | $6.36M | 48.30% | Get Alert |
05/04/2022 | AM | EDIT | Q1 | -$0.86 | -$0.79 | -$0.74 | 6.33% | $6.50M | $3.85M | $6.77M | 75.87% | Get Alert |
02/24/2022 | AM | EDIT | Q4 | -$1.00 | -$0.72 | -$0.61 | 15.28% | $11.42M | $4.29M | $12.47M | 190.65% | Get Alert |
11/08/2021 | AM | EDIT | Q3 | $0.12 | -$0.82 | -$0.57 | 30.49% | $62.84M | $4.78M | $6.20M | 29.64% | Get Alert |
08/04/2021 | AM | EDIT | Q2 | -$0.43 | -$0.83 | -$0.81 | 2.41% | $10.75M | $6.17M | $379.00K | -93.86% | Get Alert |
05/05/2021 | AM | EDIT | Q1 | -$0.69 | -$0.75 | -$0.86 | -14.67% | $5.72M | $5.14M | $6.50M | 26.44% | Get Alert |
02/25/2021 | AM | EDIT | Q4 | -$0.74 | -$0.74 | -$1.00 | -35.14% | $12.28M | $5.64M | $11.42M | 102.46% | Get Alert |
11/05/2020 | PM | EDIT | Q3 | -$0.66 | -$0.61 | $0.12 | 119.67% | $3.85M | $6.36M | $62.84M | 888.07% | Get Alert |
08/06/2020 | PM | EDIT | Q2 | -$0.69 | -$0.79 | -$0.43 | 45.57% | $2.33M | $6.34M | $10.75M | 69.54% | Get Alert |
05/07/2020 | AM | EDIT | Q1 | -$0.60 | -$0.77 | -$0.69 | 10.39% | $2.07M | $7.02M | $5.72M | -18.48% | Get Alert |
02/26/2020 | PM | EDIT | Q4 | -$0.52 | — | -$0.74 | — | $6.12M | $18.70M | $12.28M | -34.31% | Get Alert |
11/12/2019 | AM | EDIT | Q3 | -$0.32 | — | -$0.66 | — | $14.52M | — | $3.85M | — | Get Alert |
Editas Medicine (EDIT) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
The Actual EPS was $-0.23, which beat the estimate of $-0.54.
The Actual Revenue was $60M, which beat the estimate of $7.9M.
Browse earnings estimates, EPS, and revenue on all stocks.